Literature DB >> 7846237

Delusional misidentification in Alzheimer's disease: a summary of clinical and biological aspects.

H Förstl1, C Besthorn, A Burns, C Geiger-Kabisch, R Levy, A Sattel.   

Abstract

Delusional misidentification symptoms (DMS) are common in Alzheimer's disease (AD) and they are frequent sources of serious distress for patients and particularly caregivers. We observed DMS in around 30% of the patients with moderate to severe AD in two independent prospective studies; the Capgras type, phantom boarder, mirror and TV DMS were found most frequently. Patients with DMS showed increased EEG delta-power over the right hemisphere, their CT scans showed more severe right frontal lobe atrophy, and the number of their pyramidal cells in area CA1 was lower than in the patients without DMS. This may indicate that the development of DMS in AD can be promoted by certain patterns of brain degeneration which affect systems relevant to the recognition and updating of memories, while verbal skills may initially be left largely intact.

Entities:  

Mesh:

Year:  1994        PMID: 7846237     DOI: 10.1159/000284869

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  11 in total

1.  Effects of distinctive encoding on source-based false recognition: further examination of recall-to-reject processes in aging and Alzheimer disease.

Authors:  Benton H Pierce; Jill D Waring; Daniel L Schacter; Andrew E Budson
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 2.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 3.  Capgras syndrome in Parkinson's disease: two new cases and literature review.

Authors:  Antonino Cannas; Mario Meloni; Marcello Mario Mascia; Paolo Solla; Luigi Cocco; Antonella Muroni; Gianluca Floris; Francesca Di Stefano; Francesco Marrosu
Journal:  Neurol Sci       Date:  2016-11-15       Impact factor: 3.307

4.  Temporal lobe asymmetry in patients with Alzheimer's disease with delusions.

Authors:  C Geroldi; N M Akkawi; S Galluzzi; M Ubezio; G Binetti; O Zanetti; M Trabucchi; G B Frisoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 5.  Neurobiology of delusions in Alzheimer's disease.

Authors:  Zahinoor Ismail; Minh-Quan Nguyen; Corinne E Fischer; Tom A Schweizer; Benoit H Mulsant; David Mamo
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

Review 6.  Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the Era of Boxed Warnings.

Authors:  Rajesh R Tampi; Gargi Bhattacharya; Padmapriya Marpuri
Journal:  Curr Psychiatry Rep       Date:  2022-07-04       Impact factor: 8.081

7.  Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease.

Authors:  Suzanne Reeves; Richard Brown; Robert Howard; Paul Grasby
Journal:  Neurology       Date:  2009-02-10       Impact factor: 9.910

8.  Prevalence of Capgras syndrome in Alzheimer's patients: A systematic review and meta-analysis.

Authors:  Gabriela Caparica Muniz Pereira; Gustavo Carvalho de Oliveira
Journal:  Dement Neuropsychol       Date:  2019 Oct-Dec

9.  Cognitive neuroscience of delusions in aging.

Authors:  Anna E M Holt; Martin L Albert
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

Review 10.  Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

Authors:  Debby Van Dam; Yannick Vermeiren; Alain D Dekker; Petrus J W Naudé; Peter P De Deyn
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.